Literature DB >> 11056247

No evidence of somatic activating mutations on gonadotropin receptor genes in sex cord stromal tumors.

L R Giacaglia1, F Kohek MB da, F M Carvalho, M C Fragoso, B Mendonca, A C Latronico.   

Abstract

OBJECTIVE: To search for somatic activating mutations of gonadotropin receptor (FSH-R and LH/chorionic gonadotropin receptor [CG-R]) genes as a cause of sex cord stromal tumors.
DESIGN: Molecular studies in human tissue.
SETTING: University hospital. SPECIMEN(S): Eight granulosa cell tumors collected from paraffin-embedded tissue, eight Leydig cell tumors, and three thecomas collected from fresh-frozen or paraffin-embedded tissue. INTERVENTION(S): Tumor samples were used for DNA extraction. The entire exon 11 of the LH/CG-R gene and a hot spot for gonadotropin receptor activating mutations on exon 10 of the FSH-R gene were amplified by polymerase chain reaction. The former was analyzed by denaturing gradient gel electrophoresis and automatic direct sequencing, and the latter by automatic direct sequencing. MAIN OUTCOME MEASURE(S): Results of denaturing gradient gel electrophoresis and automatic direct sequencing. RESULT(S): No somatic activating mutation was detected in exon 11 of the LH/CG-R gene in eight Leydig cell tumors and three thecomas. In addition, no mutations were detected in eight granulosa cell tumors in the hot spot for activating mutations in exon 10 of the FSH-R gene. CONCLUSION(S): Somatic activating mutations of gonadotropin receptors seem to play no relevant role in the development of sex cord stromal tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11056247     DOI: 10.1016/s0015-0282(00)01565-x

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

Review 1.  Mutations in human gonadotropin and gonadotropin-receptor genes.

Authors:  I T Huhtaniemi; A P N Themmen
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 2.  Constitutive activation of G protein-coupled receptors and diseases: insights into mechanisms of activation and therapeutics.

Authors:  Ya-Xiong Tao
Journal:  Pharmacol Ther       Date:  2008-08-09       Impact factor: 12.310

3.  Synergistic effects of Pten loss and WNT/CTNNB1 signaling pathway activation in ovarian granulosa cell tumor development and progression.

Authors:  Marie-Noëlle Laguë; Marilène Paquet; Heng-Yu Fan; M Johanna Kaartinen; Simon Chu; Soazik P Jamin; Richard R Behringer; Peter J Fuller; Andrew Mitchell; Monique Doré; Louis M Huneault; Joanne S Richards; Derek Boerboom
Journal:  Carcinogenesis       Date:  2008-08-06       Impact factor: 4.944

4.  Absence of activating mutations in the hot spots of the LH receptor and Gs-alpha genes in Leydig cell tumors.

Authors:  T C A Vieira; J M Cerutti; M R Dias da Silva; R Delcelo; J Abucham
Journal:  J Endocrinol Invest       Date:  2002 Jul-Aug       Impact factor: 4.256

5.  Leydig cell tumors of the testis: a case report.

Authors:  Ancuta Augustina Gheorghisan-Galateanu
Journal:  BMC Res Notes       Date:  2014-09-18

6.  Differential expression of GRK isoforms in nonmalignant and malignant human granulosa cells.

Authors:  Denise Walker King; Rosemary Steinmetz; Heather A Wagoner; Tamara S Hannon; Lin Yuan Chen; Erica A Eugster; Ora Hirsch Pescovitz
Journal:  Endocrine       Date:  2003-11       Impact factor: 3.925

7.  Towards understanding leydigioma: do G protein-coupled estrogen receptor and peroxisome proliferator-activated receptor regulate lipid metabolism and steroidogenesis in Leydig cell tumors?

Authors:  M Kotula-Balak; E Gorowska-Wojtowicz; A Milon; P Pawlicki; W Tworzydlo; B J Płachno; I Krakowska; A Hejmej; J K Wolski; B Bilinska
Journal:  Protoplasma       Date:  2020-03-16       Impact factor: 3.356

8.  Management of Leydig cell tumors of the testis-a case report.

Authors:  P P Genov; D P Georgieva; G V Koleva; N H Kolev; V R Dunev; B A Stoykov
Journal:  Urol Case Rep       Date:  2019-10-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.